Intent to Sole Source Abbott Laboratories for Purchase of Piccolo Xpress Blood Chemistry... Tender

HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Intent to Sole Source Abbott Laboratories for Purchase of Piccolo Xpress Blood Chemistry Analyzer. The project location is USA and the tender is closing on 14 May 2024. The tender notice number is PR84730, while the TOT Ref Number is 100619000. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Intent to Sole Source Abbott Laboratories for Purchase of Piccolo Xpress Blood Chemistry Analyzer

Deadline : 14 May 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 100619000

Document Ref. No. : PR84730

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contracting Office Address : ATLANTA, GA 30333
Primary Point of Contact : Marie Claxton
utj4@cdc.gov

Secondary Point of Contact : Joselle Teran-Macaraeg
urv3@cdc.gov
USA
Email :utj4@cdc.gov

Tender Details

Description

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to procure a Point-of-Care Blood Analyzer for determining serum lipid concentration using measurements of total cholesterol and triglycerides. These measurements are used to adjust persistent organic pollutants (POPs) measurements to a serum lipid concentration basis. The requirement of a Point-of-care device is to detect the expected concentration range/have a dynamic range in human populations that includes 20 mg/dL to 500mg/dL which is expected that 1% of the general population has a triglyceride concentration of less than 40mg/dL.While it is not expected to see concentrations of triglycerides below 20mg/dL, the Piccolo Xpress Blood Chemistry Analyzer will allow POPs to measure samples at a lower range while providing accuracy, reliability, and reproducibility. The serum lipid concentration calculated from measurements of total cholesterol and triglycerides are used in the OATB to calculate an adjusted POP concentration. The use of a Point-of-Care device instead of a fully automated chemistry analyzer will substantially reduce the per sample cost when relatively small number of results are needed (100s to 1000s).We propose to contract with Abbott Laboratories located at 100 Abbott Park Rd, Abbott Park, Il 60064. Abbott has been identified as a vendor capable of providing the Piccolo Xpress Blood Analyzer needed.

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within 15 days of the issuance of this notice will be considered by the government. A determination by the...
Active Contract Opportunity Notice ID PR84730 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier CENTERS FOR DISEASE CONTROL AND PREVENTION Office CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Apr 29, 2024 04:32 pm EDT
Original Response Date: May 14, 2024 03:30 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: May 29, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6632 - ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE
NAICS Code: 621511 - Medical Laboratories

Place of Performance: North Chicago, IL 60064 USA

Documents

 Tender Notice

SSJ.pdf